Skip to content
10-K

Annual Report

SPARK THERAPEUTICS, INC.

0001609351-19-000042

← back to feed
Filed
Feb 28, 2019 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2018 · Feb 15, 2019 37.96M sh
Capex FY 2018 · Dec 31, 2018 $33.82M
Capex restated FY 2018 · Dec 31, 2017 $9.65M
Capex restated FY 2018 · Dec 31, 2016 $8.53M
Operating Cash Flow FY 2018 · Dec 31, 2018 −$70.56M
Operating Cash Flow FY 2018 · Dec 31, 2017 −$154.54M
Operating Cash Flow FY 2018 · Dec 31, 2016 −$80.44M
Long Term Debt FY 2018 · Dec 31, 2018 $46.09M
Long Term Debt restated FY 2018 · Dec 31, 2017 $912K
Short Term Debt FY 2018 · Dec 31, 2018 $4.82M
Short Term Debt restated FY 2018 · Dec 31, 2017 $312K
Cash And Equivalents FY 2018 · Dec 31, 2018 $95.25M
Cash And Equivalents restated FY 2018 · Dec 31, 2017 $96.75M
Stockholders Equity FY 2018 · Dec 31, 2018 $496.51M
Stockholders Equity restated FY 2018 · Dec 31, 2017 $513.62M
Stockholders Equity restated FY 2018 · Dec 31, 2016 $330.28M
Stockholders Equity restated FY 2018 · Dec 31, 2015 $290.54M
Current Liabilities FY 2018 · Dec 31, 2018 $62.35M
Current Liabilities restated FY 2018 · Dec 31, 2017 $53.69M
Total Liabilities FY 2018 · Dec 31, 2018 $317.84M
Total Liabilities restated FY 2018 · Dec 31, 2017 $103.17M
Current Assets FY 2018 · Dec 31, 2018 $567.14M
Current Assets restated FY 2018 · Dec 31, 2017 $533.17M
Total Assets FY 2018 · Dec 31, 2018 $814.35M
Total Assets restated FY 2018 · Dec 31, 2017 $616.8M
Eps Diluted FY 2018 · Dec 31, 2018 −$1.73
Eps Diluted FY 2018 · Sep 30, 2018 −$1.26
Eps Diluted FY 2018 · Jun 30, 2018 $2.07
Eps Diluted FY 2018 · Mar 31, 2018 −$1.25
Eps Basic FY 2018 · Dec 31, 2018 −$1.73
Eps Basic FY 2018 · Sep 30, 2018 −$1.26
Eps Basic FY 2018 · Jun 30, 2018 $2.15
Eps Basic FY 2018 · Mar 31, 2018 −$1.25
Net Income FY 2018 · Dec 31, 2018 −$65.26M
Net Income FY 2018 · Dec 31, 2018 −$78.82M
Net Income FY 2018 · Sep 30, 2018 −$47.36M
Net Income FY 2018 · Jun 30, 2018 $80.17M
Net Income FY 2018 · Mar 31, 2018 −$46.37M
Net Income restated FY 2018 · Dec 31, 2017 −$61.82M
Net Income restated FY 2018 · Dec 31, 2017 −$253.48M
Net Income restated FY 2018 · Sep 30, 2017 −$65.01M
Net Income restated FY 2018 · Jun 30, 2017 −$74.36M
Net Income restated FY 2018 · Mar 31, 2017 −$52.29M
Net Income restated FY 2018 · Dec 31, 2016 −$123.65M
Operating Income FY 2018 · Dec 31, 2018 −$58.38M
Operating Income FY 2018 · Dec 31, 2018 −$193.64M
Operating Income FY 2018 · Sep 30, 2018 −$51.75M
Operating Income FY 2018 · Jun 30, 2018 −$34.6M
Operating Income FY 2018 · Mar 31, 2018 −$48.91M
Operating Income restated FY 2018 · Dec 31, 2017 −$62.81M
Operating Income restated FY 2018 · Dec 31, 2017 −$258.52M
Operating Income restated FY 2018 · Sep 30, 2017 −$65.83M
Operating Income restated FY 2018 · Jun 30, 2017 −$77M
Operating Income restated FY 2018 · Mar 31, 2017 −$52.88M
Operating Income restated FY 2018 · Dec 31, 2016 −$125.4M
Cost Of Revenue FY 2018 · Dec 31, 2018 $2.1M
Cost Of Revenue FY 2018 · Sep 30, 2018 $318K
Cost Of Revenue FY 2018 · Jun 30, 2018 $4.51M
Cost Of Revenue FY 2018 · Mar 31, 2018 $990K
Revenue FY 2018 · Dec 31, 2018 $13.16M
Revenue FY 2018 · Dec 31, 2018 $64.73M
Revenue FY 2018 · Sep 30, 2018 $10.71M
Revenue FY 2018 · Jun 30, 2018 $25.19M
Revenue FY 2018 · Mar 31, 2018 $15.68M
Revenue FY 2018 · Dec 31, 2017 $7.41M
Revenue FY 2018 · Dec 31, 2017 $12.07M
Revenue FY 2018 · Sep 30, 2017 $1.9M
Revenue FY 2018 · Jun 30, 2017 $1.48M
Revenue FY 2018 · Mar 31, 2017 $1.27M
Revenue FY 2018 · Dec 31, 2016 $20.18M